| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 10/23/2008 | US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 10/23/2008 | US20080261950 Drug hybrid of rivastigmine or physostigmine with tranylcypromine, amoxapine, desipramine, nortriptyline, protriptyline, fluoxetine, fluvoxamine, paroxetine, duloxetine, betahistine, amlodipine, proylhexedrine, rimantadine, desloratadine; Alzheimer's disease; Parkinson's disease, impairment in memory |
| 10/22/2008 | EP1596868B1 Method for treating severe heart failure and medicament therefor |
| 10/22/2008 | CN101289426A Process for preparing restraining agent for leishmaniasis |
| 10/21/2008 | US7439397 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis |
| 10/16/2008 | US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes |
| 10/16/2008 | US20080255095 Benzylamine analogues |
| 10/16/2008 | US20080255092 6-Substituted-2,3,4,5-Tetrahydro-1H-Benzo[d]Azepines as 5-Ht2c Receptor Agonists |
| 10/16/2008 | US20080255089 Menopausal or postmenopausal disorders, vasomotor symptoms, urogenital disorders, female sexual dysfunction, breast cancer, depression, diabetes, bone demineralization, and osteoporosis; substituted 2-(p-aminoalkoxyphenyl)-1,1-diphenylethylene derivatives |
| 10/15/2008 | EP1680127B1 Benzazepine derivatives as mao-b inhibitors |
| 10/15/2008 | CN101287719A Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 10/15/2008 | CN101284813A Preparation method of ivabradine |
| 10/14/2008 | US7435824 Prodrugs of potassium channel inhibitors |
| 10/14/2008 | US7435729 using estrogen antagonist ; anticancer agents |
| 10/14/2008 | CA2309328C Cyclic amine derivatives and their use as drugs |
| 10/09/2008 | US20080249300 reacting a mixture of cyclic ketones with ammonia and hydrogen peroxide, in the presence of titanium silicalite catalysts and cocatalysts comprising a mixture of a Bronsted acid and ammonia, in solvents, to give ketone oximes, then preparing lactams by Beckmann rearrangement, using the ketone oximes |
| 10/08/2008 | EP1976385A2 Anthranilamide derivatives and their use for the control of insects and acari |
| 10/08/2008 | CN101279971A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 10/02/2008 | WO2008116308A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 10/02/2008 | US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis |
| 10/02/2008 | CA2681771A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 10/01/2008 | EP1975156A1 Method for depolymerizing polyamide and method for producing monomer of polyamide |
| 10/01/2008 | EP1399424B8 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide |
| 10/01/2008 | CN101277937A Asymmetric catalytic reduction of oxcarbazepine |
| 10/01/2008 | CN101274911A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| 09/30/2008 | US7429603 C-fms kinase inhibitors |
| 09/30/2008 | US7429579 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/25/2008 | US20080234252 2-[4-(4-Chlorophenyl)-5-(methoxymethyl)-4H-1,2,4-triazol-3-yl]isoindoline; vasopressin antagonists; dysmenorrhea, Alzheimer's disease, anorexia nervosa, anxiety, anxiety disorder, asthma, atherosclerosis, autism, cardiovascular disease |
| 09/25/2008 | US20080234251 8-Substituted Benzoazepines as Toll-Like Receptor Modulators |
| 09/25/2008 | US20080234247 Heterocyclic analgesic compounds and methods of use thereof |
| 09/25/2008 | US20080230368 Process for the purification of lactams |
| 09/24/2008 | CN101273017A Method of manufacturing benzoazepin compound or its salt |
| 09/23/2008 | US7427683 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427611 4-[(3-aminopropyl) (ethyl)amino]-2-{[1-(carboxymethyl)-2-oxo-2, 3, 4, 5-tetrahydro-1H-1benzazepin-3-yl]amino}carbonyl)-cyclopentyl]methyl}-4-oxobutanoic acid; neutral endopeptidase or human soluble endopeptidase (hSEP) inhibitors; cardiovascular diseases, apoptosis, stroke, neurodegenerative disorder |
| 09/18/2008 | WO2007104933A8 Chemical compounds |
| 09/18/2008 | US20080227771 Delta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 09/18/2008 | US20080227769 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | US20080227724 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents |
| 09/17/2008 | EP1968938A1 Substituted propiolic acid amides and their use for producing drugs |
| 09/17/2008 | EP1446383B1 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/16/2008 | US7425551 N [(S)-5-(2-hydroxy-ethyl)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-2-methyl-N '-(2,2,3,3,3-pentafluoro-propyl)-malonamide; Alzheimer's disease; cancers; gamma -secretase inhibitors; good solubility, potentiation and selectivity |
| 09/12/2008 | WO2008108639A1 Co-crystalline forms of carbamazepine |
| 09/11/2008 | US20080221320 Hydrolysis of the nitrile group of 5-cyano-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine with hydrogen peroxide, or a Group 1A or 2A perborate or persulfate, in alkaline ethanol or isopropanol and in the presence of microwaves |
| 09/11/2008 | US20080221087 Substituted lactams as inhibitors of abeta protein production |
| 09/11/2008 | US20080221083 Heterobicyclic metalloprotease inhibitors |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/10/2008 | CN101263116A Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase |
| 09/09/2008 | US7423033 Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein production |
| 09/09/2008 | US7423032 Method for treating severe heart failure and medicament therefor |
| 09/09/2008 | US7423031 Compounds and compositions as protein kinase inhibitors |
| 09/09/2008 | US7422676 Apparatus and process for the synthesis of hydrogen peroxide directly from hydrogen and oxygen |
| 09/04/2008 | WO2008105445A1 Transdermal pharmaceutical composition |
| 09/04/2008 | WO2008104589A1 Novel dosage form |
| 09/04/2008 | WO2008064887A8 A bislactamamide derivative as intermediate in the production of di i socyanate |
| 09/04/2008 | US20080214525 Alkyl 4- [4- (5-Oxo-2,3,5, 11A-Tetrahydo-5H-Pyrrolo [2, 1-C] [1,4] Benzodiazepine-8-Yloxy) -Butyrylamino]-1H-Pyrrole-2-Carboxylate Derivatives and Related Compounds For the Treatment of a Proliferative Disease |
| 09/04/2008 | US20080214523 Method for treating severe heart failure and medicament therefor |
| 09/04/2008 | US20080214520 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder |
| 09/04/2008 | CA2679525A1 Novel dosage form |
| 09/03/2008 | EP1962600A2 Metronidazole cocrystals and imipramine cocrystals |
| 09/03/2008 | EP1257541B1 Polypharmacophoric agents |
| 09/03/2008 | CN101258131A 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/28/2008 | WO2008059513A3 Compounds suitable as modulators of hdl |
| 08/28/2008 | US20080207898 Processes for the preparation of aminoethoxybenzyl alcohols |
| 08/28/2008 | US20080207897 6-Substituted-2,3,4,5-Tetrahydro-1H-Benzo[D] Azepines as 5-Ht2c Receptro Agonists |
| 08/28/2008 | US20080207602 Succinoylamino benzodiazepines as inhibitors of abeta protein production |
| 08/28/2008 | US20080206191 Compounds for the Treatment of Hepatitis C |
| 08/27/2008 | EP1960347A2 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors |
| 08/27/2008 | CN101253153A 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d] azepines as 5-HT2c receptor agonists |
| 08/27/2008 | CN101253147A Organic compounds |
| 08/27/2008 | CN101250148A Method for preparing caprolactam by phase rearrangement of cyclohexanone oxime liquid |
| 08/27/2008 | CN100413861C Compounds and methods for the treatment or prevention of flavivirus infections |
| 08/21/2008 | WO2008053393A8 Rotary actuator |
| 08/21/2008 | WO2007145922A3 Benzazepinones as sodium channel blockers |
| 08/20/2008 | EP1958938A2 A process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide |
| 08/20/2008 | EP1958937A1 Delta d Crystaline form of ivabradine hydrochloride, process of preparation thereof and pharmaceutical compositions containing the same |
| 08/20/2008 | EP1692129B1 Keto lactam compounds and use thereof |
| 08/20/2008 | EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 08/20/2008 | CN101248062A C-fms kinase inhibitors |
| 08/19/2008 | US7414078 Oral general anesthetics and metabolitically resistant anticonvulsants |
| 08/19/2008 | US7414045 Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors |
| 08/14/2008 | WO2008097546A2 Compounds that inhibit cholinesterase |
| 08/14/2008 | US20080194541 Anti-Inflammatory Agents |
| 08/14/2008 | CA2677241A1 Compounds that inhibit cholinesterase |
| 08/13/2008 | EP1956005A1 Delta d Crystaline form of ivabradine hydrochloride, process of preparation thereof and pharmaceutical compositions containing the same |
| 08/13/2008 | CN100410240C Continuous process for preparing caprolactam |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7410962 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| 08/12/2008 | US7410961 2,6-disubstituted piperiddines as modulators |
| 08/12/2008 | CA2487331C Anti-inflammatory compositions and methods of use |
| 08/07/2008 | WO2008093737A1 Amide derivative |
| 08/07/2008 | WO2008092786A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives |
| 08/07/2008 | WO2008070111A3 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| 08/07/2008 | US20080188463 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives |
| 08/07/2008 | US20080188462 reversed chloroquines; to treat chloroquine resistant/sensitive malaria parasites; N'-(7-Chloro-quinolin-4-yl)-N-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-N-methyl-propane-1,3-diamine |
| 08/07/2008 | US20080188460 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them |